CytomX Therapeutics, Inc.
ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF
Last updated:
Abstract:
Provided herein are activatable antibodies that when activated specifically bind to CD166 and conjugated activatable antibodies that specifically bind to CD166. Also provided are methods of making and using these activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Status:
Application
Type:
Utility
Filling date:
1 Nov 2019
Issue date:
27 Jan 2022